The effect of low dose amphetamine in rotenone-induced toxicity in a mice model of Parkinson’s disease

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 308

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-23-9_013

تاریخ نمایه سازی: 27 مرداد 1399

چکیده مقاله:

Objective(s): The effects of low dose amphetamine on oxidative stress and rotenone-induced neurotoxicity and liver injury were examined in vivo in a mice model of Parkinson’s disease. Materials and Methods: Male mice were treated with rotenone (1.5 mg/kg, every other day for two weeks, subcutaneously). Mice received either the vehicle or amphetamine intraperitoneally at doses of 0.5, 1.0, or 2.0 mg/kg. Oxidative stress was assessed by measurement of the lipid peroxidation product malondialdehyde (MDA), nitric oxide (NO), total anti-oxidant capacity (TAC), and paraoxonase-1 (PON-1) activity in the brain and liver. In addition, brain concentrations of nuclear factor kappa B (NF-κB) and tyrosine hydroxylase were determined and histopathology and Bax/Bcl-2 immunohistochemistry were performed. Results: The levels of lipid peroxidation and NO were increased and TAC and PON-1 were decreased significantly compared with vehicle-injected control mice. There were also significantly increased NF-κB and decreased tyrosine hydroxylase in the brain following rotenone administration. These changes were significantly attenuated by amphetamine. Rotenone caused neurodegenerative changes in the substantia nigra, cerebral cortex, and hippocampus. The liver showed degenerative changes in hepatocytes and infiltration of Kupffer cells. Bax/Bcl2 ratio was significantly increased in brain and liver tissues. Amphetamine prevented these histopathological changes and the increase in apoptosis evoked by rotenone.Conclusion: These results suggest that low dose amphetamine exerts anti-oxidant and anti-apoptotic effects, protects against rotenone-induced neurodegeneration, and could prevent neuronal cell degeneration in Parkinson’s disease.

کلیدواژه ها:

Amphetamine Anti ، oxidant capacity Neuroprotection Parkinson’s disease Reactive oxygen species Rotenone

نویسندگان

Omar M.E. Abdel-Salam

Department of Toxicology and Narcotics, National Research Centre, Cairo, Egypt

Safaa M. Youssef Morsy

Department of Medical Biochemistry, National Research Centre, Cairo, Egypt

Eman R. Youness

Department of Medical Biochemistry, National Research Centre, Cairo, Egypt

Noha N. Yassen

Department of Pathology, National Research Centre, Cairo, Egypt

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, ...
  • Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen ...
  • Rossi A, Berger K, Chen H, Leslie D, Mailman RB, ...
  • Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. ...
  • Mallet N, Delgado L, Chazalon M, Miguelez C, Baufreton J. ...
  • Jellinger KA. Recent developments in the pathology of Parkinson’s disease. ...
  • Santens P, Boon P, Van Roost D, Caemaert J. The ...
  • Blesa J, Trigo-Damas I, Quiroga-Varela A,  Jackson-Lewis VR. Oxidative stress ...
  • De Virgilio A, Greco A, Fabbrini G, Inghilleri M, Rizzo ...
  • Halliwell B. Oxidative stress and neurodegeneration: where are we now ...
  • Nagatsu T, Sawada M. Biochemistry of postmortem brains in Parkinson’s ...
  • Hirsch EC, Hunot S. Neuroinflammation in Parkinson’s disease: a target ...
  • Ritz BR, Paul KC, Bronstein JM. Of pesticides and men: ...
  • Sherer TB, Kim JH, Betarbet R, Greenamyre JT. Subcutaneous rotenone ...
  • Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, ...
  • Liu HQ, Zhu XZ, Weng EQ. Intracellular dopamine oxidation mediates ...
  • Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, ...
  • Grivennikova VG, Vinogradov AD. Generation of superoxide by the mitochondrial ...
  • Schapira AHV, Emre M, Jenner P, Poewe W. Levodopa in ...
  • Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a ...
  • Rascol O, Lozano A, Stern M, Poewe W. Milestones in ...
  • Abdel-Salam OME. Drug therapy for Parkinson’s disease: an update. World ...
  • Berman S, O’Neill J, Fears S, Bartzokis G, London ED. ...
  • Janssen PA, Leysen JE, Megens AA, Awouters FH. Does phenylethylamine ...
  • Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, ...
  • Sitte HH, Freissmuth M. Amphetamines, new psychoactive drugs and the ...
  • Koirala S, Shah S, Khanal L. Effect of D‐amphetamine on ...
  • Halpin LE, Collins SA, Yamamoto BK. Neurotoxicity of methamphetamine and ...
  • Papadopoulos CM, Tsai S-Y, Guillen V, Ortega J, Kartje GL, ...
  • Byard RW, Donkin J, Vink R. The forensic implications of ...
  • Richter F, Hamann M, Richter A. Chronic rotenone treatment induces ...
  • Abdel-Salam OME, Youness ER, Ahmed NA, El-Toumy SA, Souleman AMA, ...
  • Nair V, Turner GA. The thiobarbituric acid test for lipid ...
  • Moshage H, Kok B, Huizenga JR. Nitrite and nitrate determination ...
  • Koracevic D, Koracevic G, Djordjevic V. Method for the measurement ...
  • Haagen L, Brock A. A new automated method for phenotyping ...
  • Drury RVA, Walligton EA. Carltons histological techniques, 5th edn., 1980. ...
  • Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, ...
  • Bashkatova V, Alam M, Vanin A, Schmidt WJ. Chronic administration ...
  • Abdel-Salam OME, Omara EA, El-Shamarka ME-S, Hussein JS. Nigrostriatal damage ...
  • Liu C, Wang R, Ji T, Fan Y, Qin Z, ...
  • Testa CM, Sherer TB, Greenamyre JT. Rotenone induces oxidative stress ...
  • Ibrahim NA, Abdel-Salam OM, Khadrawy YA, Hashem AM, Sameer EM. ...
  • Abdel-Salam OME, Sleem AA, Youness ER, Mohammed NA, Omara EA, ...
  • Kusano C, Ferrari B. Total anti-oxidant capacity: a biomarker in ...
  • He Y, Imam SZ, Dong Z, Jankovic J, Ali SF, ...
  • Abdel-Salam OE, Omara EA, Youness ER, Khadrawy YA, Mohammed NA, ...
  • Xiong N, Xiong J, Jia M, Liu L, Zhang X, ...
  • Wink DA, Feelisch M, Vodovotz Y, Fukuto J, Grisham MB. ...
  • Brown GC. Nitric oxide and neuronal death. Nitric Oxide 2010; ...
  • Gao B, Chang C, Zhou J, Zhao T, Wang C, ...
  • Abdel-Salam OME, Youness ER, Mohammed NA, Yassen NN, Shaffie N, ...
  • Moynagh PN. The NF-κB pathway. J Cell Sci 118: 4389-4392. ...
  • Turner MD, Nedjai B, Hurst T,  Pennington  DJ. Cytokines and ...
  • Bowie A, O’Neill LA. Oxidative stress and nuclear factor-kappaB activation: ...
  • Androutsopoulos VP, Kanavouras K, Tsatsakis AM. Role of paraoxonase 1 ...
  • Costa LG, Li WF, Richter RJ, Shih DM, Lusis A, ...
  • Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, ...
  • Narayan S, Liew Z, Paul K, Lee PC, Sinsheimer JS, ...
  • Furlong CE, Marsillach J, Jarvik GP, Costa LG. Paraoxonases-1, -2 ...
  • Abdel-Salam OME, Youness ER, Mohammed NA, Abu Elhamed WA. Nuclear ...
  • Jamroz-Wisniewska A, Beltowski J, Stelmasiak Z, Bartosik-Psujek H. Paraoxonase 1 ...
  • Wehr H, Bednarska-Makaruk M, Graban A, Lipczynska-Lojkowska W, Rodo M, ...
  • Zhou Q, Liu C, Liu W, Zhang H, Zhang R, ...
  • Brunelle JK , Letai A. Control of mitochondrial apoptosis by ...
  • Watabe M, Nakaki T. Rotenone induces apoptosis via activation of ...
  • Kim HJ, Park HJ, Park HK, Chung JH.Tranexamic acid protects ...
  • Badiani A, Oates MM, Day HEW, Watson SJ, Akil H, ...
  • Underhill SM, Hullihen PD, Chen J, Fenollar-Ferrer C, Rizzo MA, ...
  • Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, ...
  • Abdel-Salam OME, Sleem AA, Youness ER, Yassen NN, Shaffie N, ...
  • نمایش کامل مراجع